Treatment of aortic valve endocarditis with stented or stentless valve.

ABSTRACT:

Objective

The study objective was to provide evidence for choosing a bioprosthesis in treating patients with active aortic valve endocarditis.

Methods

From 1998 to 2017, 265 patients with active aortic valve endocarditis underwent aortic valve replacement with a stented valve (n = 97, 37%) or a stentless valve (n = 168, 63%) with further breakdown into inclusion technique (n = 142, 85%) or total root replacement (n = 26, 15%). Data were obtained from the Society of Thoracic Surgeons database aided with chart review, surveys, and National Death Index data.

Results

The median age of patients was 53 years (43-56) in the stented group and 57 years (44-66) in the stentless group. The stented and stentless groups had high rates of heart failure (54% and 40%), liver disease

SUBMITTER: Clemence J 

PROVIDER: S-EPMC7907285 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature